by Gary Hu
Volume 8, Issue 3 (Fall 2009)
Amino acids are the most basic of building blocks in physiology, which is why peptides (oligomers of amino acids) are continuing to grow in prominence among pharmaceutical manufacturers. With inherent abilities to block and/or enhance signal transfers in the human body, peptides, when harnessed as active pharmaceutical ingredients, can treat a host of metabolic diseases, cardiovascular and heart conditions, and neurodegenerative disorders. Peptide-based drug targets are being identified at an increasingly rapid pace, both in terms of recently introduced therapies, and products in the development pipeline…
Citation:
Hu G. Peptide Synthesis in Pharmaceutical Manufacturing. BioProcess J, 2009; 8(3): 51-53. http://dx.doi.org/10.12665/J83.Hu